What is the plasma therapy market size?

The plasma therapy market size is valued at USD 1.2 billion as of 2023.

What is the growth forecast for the plasma therapy market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the plasma therapy market?

Increasing demand for plasma-derived therapies drives the market.

What are the challenges facing the plasma therapy market?

Stringent regulations and high production costs are major challenges.

Which regions are leading the plasma therapy market?

North America and Europe are the leading regions.

Who are the top companies in the plasma therapy market?

Leading companies include Grifols and CSL Behring.

What are the future opportunities in the plasma therapy market?

Emerging economies and new indications offer future opportunities.

How is technology impacting the plasma therapy market?

Advances in plasma collection and processing technology are improving efficiency.

What is the regulatory landscape for the plasma therapy market?

Regulatory frameworks vary by region, with the FDA and EMA playing key roles.

What is the future outlook for the plasma therapy market?

The market is expected to grow significantly due to increasing demand.

plasma therapy Strategic Analysis & Growth Outlook 2033

plasma therapy by Application (Orthopedic, Darmatology, Cardiac Muscle Injury, Dental, Nerve Injury), by Types (Pure PRP, Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 0.25%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 0.25%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

plasma therapy Market Overview

The plasma therapy market refers to the industry that utilizes plasma, a component of blood, to treat various medical conditions. As a rapidly evolving field, the plasma therapy market size is estimated to be around $4.8 billion in 2025. The growth outlook for this market is promising, with a market forecast expecting significant expansion over the forecast period. The plasma therapy market is poised for substantial growth, driven by increasing demand for effective treatments and the rising prevalence of diseases such as immunodeficiency disorders, neurological disorders, and certain types of cancer. Key synonyms include plasma-derived therapies and blood plasma treatments. The scope of this market encompasses various types of plasma therapies, including hyperimmune globulin, intravenous immunoglobulin (IVIG), and albumin.

Loading chart…

The plasma therapy market is expected to grow at a CAGR of around 7-8% from 2026 to 2033, driven by macro drivers such as increasing healthcare expenditure, advancements in technology, and rising awareness about plasma-derived therapies. Key forces shaping the industry include technology shifts towards more efficient plasma collection and processing methods, regulatory frameworks that ensure the safety and quality of plasma-derived products, and consumer behavior that favors more targeted and effective treatments. The largest region in the plasma therapy market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand for plasma-derived therapies in countries such as China and India. Overall, the plasma therapy market is poised for significant growth, driven by increasing demand for effective treatments and the rising prevalence of diseases that can be treated with plasma-derived therapies.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	13.06 million
Growth rate	CAGR of 0.25% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo; Arthrex; Zimmer Biomet; DePuy Synthes; EmCyte; Regen Lab; ISTO Biologics; Cesca Therapeutics; Weigao; REV-MED; Nuo Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The plasma therapy market is poised for significant growth, driven by increasing demand for effective treatments and advancements in technology. The market dynamics are shaped by various factors, including growth drivers, restraints, opportunities, and challenges, which are crucial in determining the plasma therapy market size and growth forecast.

Growth Drivers2 items

Rising prevalence of chronic diseases, such as cancer and autoimmune disorders, is driving the demand for plasma therapy market treatments, leading to increased investment in research and development

Advances in plasma collection and processing technologies are improving the safety and efficacy of plasma-derived therapies, contributing to the growth of the plasma therapy market size

Restraints2 items

Stringent regulatory requirements and high production costs are limiting the entry of new players in the plasma therapy market, thereby restricting market growth

Risk of transmission of infectious diseases through plasma-derived products is a major concern, affecting the growth forecast of the market

Opportunities2 items

Emerging economies, such as Asia Pacific, offer significant opportunities for the plasma therapy market due to increasing healthcare expenditure and growing demand for advanced treatments

Development of new plasma-derived therapies for rare and orphan diseases is expected to drive growth in the plasma therapy market size, with many companies investing in research and development

Challenges2 items

Ensuring the quality and safety of plasma-derived products is a major challenge, requiring significant investment in testing and validation procedures, which can impact the plasma therapy market

Competition from alternative therapies, such as gene therapy and cell therapy, is a significant challenge for the plasma therapy market, requiring companies to innovate and differentiate their products

Market Segmentation

Loading chart…

The plasma therapy market can be segmented based on application, which refers to the specific use cases of plasma therapy. This segmentation category contributes significantly to the overall plasma therapy market size, as different applications have varying levels of demand and growth potential. The plasma therapy segmentation by application includes subtypes such as wound healing, orthopedic treatments, and dermatological treatments, among others.

Another crucial segmentation category in the plasma therapy market is types, which encompasses various subtypes, including platelet-rich plasma (PRP) and plasma protein fractionation. Each subtype has distinct characteristics, advantages, and limitations, influencing the market dynamics and growth prospects. Understanding the types of plasma therapy is essential for stakeholders to navigate the market effectively and capitalize on emerging opportunities, ultimately informing the plasma therapy segmentation and market taxonomy.

plasma therapy Segmentation Breakdown10 items

Application

Orthopedic

Darmatology

Cardiac Muscle Injury

Dental

Nerve Injury

Types

Pure PRP

Leucocyte-rich PRP

Leukocyte-rich Fibrin (L-PRF)

Regional Insights

Loading chart…

The plasma therapy market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of plasma therapy, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include a strong regulatory framework, increasing adoption of plasma therapy, and a high level of ecosystem maturity. Asia Pacific is driven by a large and growing population, increasing investments in healthcare, and a rising awareness of plasma therapy. Latin America and Middle East & Africa are driven by improving infrastructure, growing demand for plasma therapy, and increasing government support.

The regional forecast indicates that Asia Pacific will experience the highest plasma therapy market growth, driven by China and India. North America and Europe will maintain their market share, while Latin America and Middle East & Africa will experience moderate growth. Understanding these regional dynamics is crucial for stakeholders to navigate the global plasma therapy market effectively.

Competitive Landscape

The plasma therapy market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The plasma therapy competitive landscape is driven by the ability of companies to navigate complex regulatory environments and establish strong distribution networks. Key competitive levers include pricing strategies, partnerships with healthcare providers, and investments in research and development to drive product innovation.

Companies in the plasma therapy market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and expansion into new markets. Common differentiation strategies include investments in technology, development of unique service models, and establishment of strong channel partnerships. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks, which can impact their ability to compete effectively. Some of the key companies and their strategies include:

Terumo: regional expansion

Arthrex: premium pricing

Zimmer Biomet: innovation pipeline

DePuy Synthes: local manufacturing

EmCyte: OEM tie-ups

Regen Lab: vertical integration

Key plasma therapy Companies11 items

Terumo

Arthrex

Zimmer Biomet

DePuy Synthes

EmCyte

Regen Lab

ISTO Biologics

Cesca Therapeutics

Weigao

REV-MED

Nuo Therapeutics

Market Ecosystem

The plasma therapy ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and delivery of plasma therapy products and services. The plasma therapy ecosystem is interconnected, with each segment influencing the others, and its boundaries are defined by the flow of goods, services, and information.

Raw material suppliers — provide plasma and other essential components

Technology providers — develop plasma therapy technologies and equipment

OEMs / manufacturers — produce plasma therapy products

System integrators / EPCs — integrate plasma therapy systems

Distributors / channel partners — distribute plasma therapy products

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce plasma therapy standards

In the plasma therapy ecosystem, value flows through the interactions and relationships among participants. Control points, such as regulatory approvals and standards, influence the adoption of plasma therapy products and services. Dependency risks, including input constraints and approvals, can impact the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can affect the ecosystem's dynamics. A thorough value chain analysis of the plasma therapy ecosystem is essential to understanding these complex relationships and identifying potential bottlenecks.

Recent Industry Insights

The plasma therapy industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between research institutions and pharmaceutical companies, have driven innovation in the field. Notable mergers and acquisitions have also taken place, enabling companies to expand their product portfolios and strengthen their market presence. Furthermore, several product and technology launches have been observed, including the introduction of new plasma-derived therapies and advancements in plasma collection and processing technologies.

Regulatory changes, such as updated guidelines for plasma collection and storage, have also impacted the industry. Additionally, there has been a shift in consumer trends, with increasing awareness and acceptance of plasma therapy as a treatment option. Funding rounds and expansions have been secured by several companies, allowing them to invest in research and development and scale up their operations. These developments are expected to shape the future of the plasma therapy industry and drive growth in the coming years.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the plasma therapy market. The plasma therapy market outlook is highly attractive, driven by increasing demand for effective treatments and advancements in technology. The competitive intensity is moderate, with key players focusing on innovation and expansion. The long-term outlook is promising, with potential applications in various therapeutic areas.

The innovation landscape is rapidly evolving, with ongoing research and development in plasma-derived therapies. The demand-supply balance is expected to be stable, with manufacturers ramping up production to meet growing demand. However, key risk factors such as regulatory challenges and supply chain disruptions may impact the market. Overall, the plasma therapy market offers significant opportunities for growth and investment, driven by its strong market outlook and potential for innovation.

11 items

1. Executive Summary

2. plasma therapy Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global plasma therapy Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global plasma therapy Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Orthopedic

6.1.2. Darmatology

6.1.3. Cardiac Muscle Injury

6.1.4. Dental

6.1.5. Nerve Injury

6.2. Global plasma therapy Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Pure PRP

6.2.2. Leucocyte-rich PRP

6.2.3. Leukocyte-rich Fibrin (L-PRF)

6.3. Global plasma therapy Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global plasma therapy Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global plasma therapy Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global plasma therapy Market Competition by Key Manufacturers

8.1. Global plasma therapy Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global plasma therapy: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Terumo

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Arthrex

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Zimmer Biomet

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. DePuy Synthes

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. EmCyte

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Regen Lab

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. ISTO Biologics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Cesca Therapeutics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Weigao

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. REV-MED

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Nuo Therapeutics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global plasma therapy Market

Figure 4: Global plasma therapy Market: Drivers

Figure 5: Global plasma therapy Market: Challenges

Figure 6: Global plasma therapy Market: Trends

Figure 7: Global plasma therapy Market: Opportunity

Figure 8: Global plasma therapy Market: Restraint

Figure 9: Global plasma therapy Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global plasma therapy Market Value (USD Million) By Region

Figure 15: Global plasma therapy Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global plasma therapy Market Value (USD Million) By Region

Figure 23: Global plasma therapy Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global plasma therapy Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global plasma therapy Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global plasma therapy Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global plasma therapy Market Value (USD Million) By Region

Table 10: Global plasma therapy Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global plasma therapy Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global plasma therapy Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global plasma therapy Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Terumo Basic Information And Sales Area

Table 31: Terumo. Products Portfolio

Table 32: Arthrex Basic Information And Sales Area

Table 33: Arthrex. Products Portfolio

Table 34: Zimmer Biomet Basic Information And Sales Area

Table 35: Zimmer Biomet. Products Portfolio

Table 36: DePuy Synthes Basic Information And Sales Area

Table 37: DePuy Synthes. Products Portfolio

Table 38: EmCyte Basic Information And Sales Area

Table 39: EmCyte. Products Portfolio

Table 40: Regen Lab Basic Information And Sales Area

Table 41: Regen Lab. Products Portfolio

Table 42: ISTO Biologics Basic Information And Sales Area

Table 43: ISTO Biologics. Products Portfolio

Table 44: Cesca Therapeutics Basic Information And Sales Area

Table 45: Cesca Therapeutics. Products Portfolio

Table 46: Weigao Basic Information And Sales Area

Table 47: Weigao. Products Portfolio

Table 48: REV-MED Basic Information And Sales Area

Table 49: REV-MED. Products Portfolio

Table 50: Nuo Therapeutics Basic Information And Sales Area

Table 51: Nuo Therapeutics. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global plasma therapy Market Value (USD Million) By Region

Table 57: Global plasma therapy Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

plasma therapy Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	13.06 million
Growth rate	CAGR of 0.25% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Terumo; Arthrex; Zimmer Biomet; DePuy Synthes; EmCyte; Regen Lab; ISTO Biologics; Cesca Therapeutics; Weigao; REV-MED; Nuo Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in plasma collection and processing technologies are improving the safety and efficacy of plasma-derived therapies, contributing to the growth of the plasma therapy market size

Restraints2 items

Stringent regulatory requirements and high production costs are limiting the entry of new players in the plasma therapy market, thereby restricting market growth

Risk of transmission of infectious diseases through plasma-derived products is a major concern, affecting the growth forecast of the market

Opportunities2 items

Emerging economies, such as Asia Pacific, offer significant opportunities for the plasma therapy market due to increasing healthcare expenditure and growing demand for advanced treatments

Development of new plasma-derived therapies for rare and orphan diseases is expected to drive growth in the plasma therapy market size, with many companies investing in research and development

Challenges2 items

Market Segmentation

Loading chart…

plasma therapy Segmentation Breakdown10 items

Application

Orthopedic

Darmatology

Cardiac Muscle Injury

Dental

Nerve Injury

Types

Pure PRP

Leucocyte-rich PRP

Leukocyte-rich Fibrin (L-PRF)

Regional Insights

Loading chart…

Competitive Landscape

Terumo: regional expansion

Arthrex: premium pricing

Zimmer Biomet: innovation pipeline

DePuy Synthes: local manufacturing

EmCyte: OEM tie-ups

Regen Lab: vertical integration

Key plasma therapy Companies11 items

Terumo

Arthrex

Zimmer Biomet

DePuy Synthes

EmCyte

Regen Lab

ISTO Biologics

Cesca Therapeutics

Weigao

REV-MED

Nuo Therapeutics

Market Ecosystem

Raw material suppliers — provide plasma and other essential components

Technology providers — develop plasma therapy technologies and equipment

OEMs / manufacturers — produce plasma therapy products

System integrators / EPCs — integrate plasma therapy systems

Distributors / channel partners — distribute plasma therapy products

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce plasma therapy standards

Recent Industry Insights

Analyst Overview

Table of Contents